TSC1 Sets the Rate of Ribosome Export and Protein Synthesis through Nucleophosmin Translation
- 15 February 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (4), 1609-1617
- https://doi.org/10.1158/0008-5472.can-06-2875
Abstract
Nucleophosmin (B23) is a nucleolar phosphoprotein that has been implicated in numerous cellular processes. In particular, nucleophosmin interacts with nucleolar components of newly synthesized ribosomes to promote ribosome nuclear export. Nucleophosmin is a classic mitogen-induced protein, with changes in its expression correlating with growth factor stimulation. In this study, we examined the underlying mechanism of nucleophosmin induction and showed that hyperproliferative signals emanating from oncogenic H-RasV12 cause tremendous increases in nucleophosmin protein expression. Nucleophosmin protein accumulation was dependent on mammalian target of rapamycin (mTOR) activation, as rapamycin completely prevented nucleophosmin induction. Consistent with this finding, genetic ablation of Tsc1, a major upstream inhibitor of mTOR, resulted in nucleophosmin protein induction through increased translation of existing nucleophosmin mRNAs. Increases in nucleophosmin protein accumulation were suppressed by reintroduction of TSC1. Induction of nucleophosmin through Tsc1 loss resulted in a greater pool of actively translating ribosomes in the cytoplasm, higher overall rates of protein synthesis, and increased cell proliferation, all of which were dependent on efficient nucleophosmin nuclear export. Nucleophosmin protein accumulation in the absence of Tsc1 promoted the nuclear export of maturing ribosome subunits, providing a mechanistic link between TSC1/mTOR signaling, nucleophosmin-mediated nuclear export of ribosome subunits, protein synthesis levels, and cell growth. [Cancer Res 2007;67(4):1609–17]Keywords
This publication has 51 references indexed in Scilit:
- Nucleophosmin Is Essential for Ribosomal Protein L5 Nuclear ExportMolecular and Cellular Biology, 2006
- Nucleolar Adaptation in Human CancerCancer Investigation, 2005
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- Signaling control of mRNA translation in cancer pathogenesisOncogene, 2004
- Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKRPublished by Elsevier BV ,2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature, 2003
- Mapping the Functional Domains of Nucleolar Protein B23Published by Elsevier BV ,2000
- SHP-2 binds to Tyr763 and Tyr1009 in the PDGF β-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxisOncogene, 1999
- Down-Regulation of Nucleophosmin/B23 mRNA Delays the Entry of Cells into MitosisBiochemical and Biophysical Research Communications, 1999
- Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activityOncogene, 1997